Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
6.21
+0.14 (2.31%)
At close: Jan 30, 2025, 4:00 PM
6.16
-0.05 (-0.81%)
Pre-market: Jan 31, 2025, 7:52 AM EST
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 557 employees as of December 31, 2023. The number of employees increased by 54 or 10.74% compared to the previous year.
Employees
557
Change (1Y)
54
Growth (1Y)
10.74%
Revenue / Employee
$163,120
Profits / Employee
-$736,081
Market Cap
1.89B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
IOVA News
- 13 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 17 days ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
- 22 days ago - Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market - CNBC
- 2 months ago - Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer - GlobeNewsWire
- 2 months ago - Iovance Biotherapeutics Q3: A Beat, But A Selloff - Now A Buy Opportunity - Seeking Alpha
- 3 months ago - Iovance Biotherapeutics, Inc. (IOVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024 - GlobeNewsWire
- 3 months ago - Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024 - GlobeNewsWire